Reports from China indicate that authorities are continuing an antitrust investigation into Nvidia, finding the US chipmaker culpable of market monopolization. The State Administration for Market Regulation (SAMR) launched a probe into the US giant on suspicion of monopolizing the market and discriminating against Chinese companies, particularly regarding its 2020 acquisition of Mellanox Technologies.
The ongoing investigation has cast further doubt on Nvidia's revenue from China. The company recently stated in a report that it would not be publishing China sales data for the coming quarters due to significant uncertainty. Earlier this year, investors reacted euphorically to reports that tech companies like Nvidia would be granted permission to export high-tech products to China in exchange for a 15 percent tax on sales to the country's federal budget.
Nvidia's China sales have already fallen sharply, from 26 percent to around 17 percent of total revenue, following the introduction of US export restrictions. However, the main challenges now stem from China itself, including the ongoing antitrust probe and the drive for domestic chip production, such as by Alibaba. Nvidia shares fell 2 percent in pre-market trading, and the Nasdaq 100 retreated around 75 points following the news.
Daily summary: Nervous anticipation, SaaS sell-off and weak macro data
“SaaS-pocalypse” continued
Three Markets to Watch in the Week Ahead (10.04.2026)
BREAKING: University of Michigan - weaker consument, higher inflation
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
